Literature DB >> 11755264

Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics.

Elizabeta B Mukaetova-Ladinska1, J Hurt, W G Honer, C R Harrington, C M Wischik.   

Abstract

The pathobiology of schizophrenia is poorly understood, and many neuroanatomical domains have been considered to underlie the pathophysiology of the disease. There is considerable clinical and neuroradiological evidence to support cerebellar involvement in the schizophrenic illness. We have analysed the changes in synaptic and cytoskeletal proteins in the cerebellum associated with schizophrenia. The cerebellar expression of tau and MAP2 proteins is similar in schizophrenia to that detected in age-matched controls, whereas the level of SNAP-25 is significantly depleted in the schizophrenic cerebellum. Other synaptic proteins, such as synaptophysin and syntaxin, are not affected. This provides evidence that alterations of the cerebellar synaptic network occur in schizophrenia. These changes may influence cerebellar-forebrain connections, especially those with the frontal lobes, and give rise to the cognitive dysmetria that is characteristic of the clinical phenotype in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755264     DOI: 10.1016/s0304-3940(01)02458-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Association between a synaptosomal protein (SNAP-25) gene polymorphism and verbal memory and attention in patients with endogenous psychoses and mentally healthy subjects.

Authors:  V E Golimbet; M V Alfimova; I K Gritsenko; T V Lezheiko; O M Lavrushina; L I Abramova; V G Kaleda; A N Barkhatova; A V Sokolov; R P Ebstein
Journal:  Neurosci Behav Physiol       Date:  2010-05

Review 2.  SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond.

Authors:  Renata Basso Cupertino; Djenifer B Kappel; Cibele Edom Bandeira; Jaqueline Bohrer Schuch; Bruna Santos da Silva; Diana Müller; Claiton Henrique Dotto Bau; Nina Roth Mota
Journal:  J Neural Transm (Vienna)       Date:  2016-02-08       Impact factor: 3.575

Review 3.  Imaging phenotypes and genotypes in schizophrenia.

Authors:  Jessica A Turner; Padhraic Smyth; Fabio Macciardi; James H Fallon; James L Kennedy; Steven G Potkin
Journal:  Neuroinformatics       Date:  2006

4.  Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders.

Authors:  Jennifer K Forsyth; Amanda R Bolbecker; Crystal S Mehta; Mallory J Klaunig; Joseph E Steinmetz; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2010-12-09       Impact factor: 9.306

Review 5.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

6.  Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.

Authors:  Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03-17       Impact factor: 5.270

7.  Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.

Authors:  Carmit Nadri; Galila Agam
Journal:  J Mol Neurosci       Date:  2008-07-15       Impact factor: 3.444

8.  Increased stability of microtubules in cultured olfactory neuroepithelial cells from individuals with schizophrenia.

Authors:  Alan S Brown; Karin Borgmann-Winter; Chang-Gyu Hahn; Lorna Role; David Talmage; Raquel Gur; Jacky Chow; Patric Prado; Thelma McCloskey; Yuanyuan Bao; J Chloe Bulinski; Andrew J Dwork
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-10-24       Impact factor: 5.067

9.  Upregulation of NRG-1 and VAMP-1 in human brain aggregates exposed to clozapine.

Authors:  Gursharan Chana; Ginger Lucero; Shahid Salaria; Jean Lozach; Pinyi Du; Christopher Woelk; Ian Everall
Journal:  Schizophr Res       Date:  2009-06-07       Impact factor: 4.939

10.  A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.

Authors:  Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.